Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Life Science Awards.
Digitise manufacturing with Peak Technologies
Author: April Lara
Peak Technologies helps you streamline production, reduce errors, and stay ahead with intelligent MES solutions.
Meet the 2024 Pharma Industry Awards Winners
Author: April Lara
Watch the Winner's Circle video to celebrate the outstanding achievements of the 2024 Pharma Industry Awards winners.
Regulatory headwinds amidst M&A boom in Irish life sciences
Author: April Lara
M&A deals are heating up in Ireland's life sciences sector. But can companies navigate the challenges with growing regulations and AI's impact?
Are public-private partnerships the future of clinical trials?
Author: April Lara
Public-private partnerships are reshaping clinical trials. Ireland’s new oversight group and the VPAG investment programme aim to boost efficiency and attract global research.
Pharma and DTx for better patient care
Author: April Lara
Regulatory winds are blowing in favour of DTx, which could benefit pharma companies significantly.
BioPharmaChem Ireland demands cash to keep Ireland at forefront of world pharma sector
Author: Chris Wheal
More cash for universities and research needed to keep Ireland attractive to foreign pharma firms
UK must alter approval regime so thousands more patients benefit from future cell and gene therapies
Author: Chris Wheal
UK’s National Institute for Health and Care Excellence (NICE) can help 10,000 NHS patients a year benefit from Advanced Therapy Medicinal Products
AI leverages unstructured data to accelerate drug development
Author: April Lara
From identifying new targets to optimising clinical trials, AI is accelerating the development of life-saving treatments.
Pharma pollution crisis grips UK rivers
Author: April Lara
Drug residues from our medicine cabinets are polluting UK rivers, threatening wildlife and sparking a political showdown.
IPHA stands firm as payments to healthcare staff and organisations come under scrutiny again
Author: Chris Wheal
Transparency campaigner lists criticism of IPHA database on transfers of value – money paid directly or indirectly to healthcare professionals and their employers
